Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Caravaggio

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
British Journal of Clinical Pharmacology|February 3, 2022
MAP Bayesian modelling combining striatal dopamine receptor occupancy and plasma concentrations to optimize antipsychotic dose regimens in individual patientsMohamed Ismail, Thomas Straubinger, Hiroyuki Uchida, et al.
Drug and Alcohol Dependence|January 18, 2022
A measure of subjective substance use disorder awareness - Substance Use Awareness and Insight Scale (SAS)Julia Kim, Yasaman Kambari, Anmol Taggar, et al.
JAMA Psychiatry|July 2, 2015
Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy StudyAriel Graff-Guerrero, Tarek K Rajji, Benoit H Mulsant, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 23, 2017
Reduced insulin sensitivity may be related to less striatal glutamate: An <sup>1</sup>H-MRS study in healthy non-obese humansFernando Caravaggio, Yusuke Iwata, Eric Plitman, et al.
Journal of Alzheimer'S Disease : JAD|May 17, 2017
Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease PathologyJun Ku Chung, Eric Plitman, Shinichiro Nakajima, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 18, 2016
Cognition and Dopamine D<sub>2</sub> Receptor Availability in the Striatum in Older Patients with SchizophreniaTarek K Rajji, Benoit H Mulsant, Shinichiro Nakajima, et al.
Journal of Alzheimer'S Disease : JAD|January 31, 2015
Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive ImpairmentJun Ku Chung, Eric Plitman, Shinichiro Nakajima, et al.
The International Journal of Neuropsychopharmacology|February 27, 2015
Reduced insulin sensitivity is related to less endogenous dopamine at D2/3 receptors in the ventral striatum of healthy nonobese humansFernando Caravaggio, Carol Borlido, Margaret Hahn, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 28, 2014
Glutamate-mediated excitotoxicity in schizophrenia: a reviewEric Plitman, Shinichiro Nakajima, Camilo de la Fuente-Sandoval, et al.
Biological Psychiatry|November 4, 2018
Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy StudyYusuke Iwata, Shinichiro Nakajima, Eric Plitman, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
British Journal of Clinical Pharmacology|February 3, 2022
MAP Bayesian modelling combining striatal dopamine receptor occupancy and plasma concentrations to optimize antipsychotic dose regimens in individual patientsMohamed Ismail, Thomas Straubinger, Hiroyuki Uchida, et al.
Drug and Alcohol Dependence|January 18, 2022
A measure of subjective substance use disorder awareness - Substance Use Awareness and Insight Scale (SAS)Julia Kim, Yasaman Kambari, Anmol Taggar, et al.
JAMA Psychiatry|July 2, 2015
Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy StudyAriel Graff-Guerrero, Tarek K Rajji, Benoit H Mulsant, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 23, 2017
Reduced insulin sensitivity may be related to less striatal glutamate: An <sup>1</sup>H-MRS study in healthy non-obese humansFernando Caravaggio, Yusuke Iwata, Eric Plitman, et al.
Journal of Alzheimer'S Disease : JAD|May 17, 2017
Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease PathologyJun Ku Chung, Eric Plitman, Shinichiro Nakajima, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 18, 2016
Cognition and Dopamine D<sub>2</sub> Receptor Availability in the Striatum in Older Patients with SchizophreniaTarek K Rajji, Benoit H Mulsant, Shinichiro Nakajima, et al.
Journal of Alzheimer'S Disease : JAD|January 31, 2015
Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive ImpairmentJun Ku Chung, Eric Plitman, Shinichiro Nakajima, et al.
The International Journal of Neuropsychopharmacology|February 27, 2015
Reduced insulin sensitivity is related to less endogenous dopamine at D2/3 receptors in the ventral striatum of healthy nonobese humansFernando Caravaggio, Carol Borlido, Margaret Hahn, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 28, 2014
Glutamate-mediated excitotoxicity in schizophrenia: a reviewEric Plitman, Shinichiro Nakajima, Camilo de la Fuente-Sandoval, et al.
Biological Psychiatry|November 4, 2018
Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy StudyYusuke Iwata, Shinichiro Nakajima, Eric Plitman, et al.
Pageof 9